BM 06.022: A Novel Recombinant Plasminogen Activator

This publication has 26 references indexed in Scilit:

• Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro
  Blood Coagulation & Fibrinolysis, 1993
• Rapid Reversal of Canine Thromboembolic Pulmonary Hypertension by Bolus Injection of the Novel Recombinant Plasminogen Activator BM 06.022
  Journal of Cardiovascular Pharmacology, 1993
• Thrombolytic Therapy for Acute Myocardial Infarction
  Drugs, 1992
• Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates
  Protein Science, 1992
• Double bolus administration of the novel recombinant plasminogen activator BM 06.022 improves coronary blood flow after reperfusion in a canine model of coronary thrombosis
  Blood Coagulation & Fibrinolysis, 1992
• Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis
  Journal of the American College of Cardiology, 1992
• Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• Serpin-resistant mutants of human tissue-type plasminogen activator
  Nature, 1989
• Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1987
• Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATION
  Journal of Clinical Investigation, 1983